| Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001 |
Paclitaxel |
Bristol-Myers Squibb Pharma EEIG |
— |
| AUGTYRO 160 mg hard capsules EU/1/24/1883/003-004 |
Repotrectinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| AUGTYRO 40 mg hard capsules EU/1/24/1883/001-002 |
Repotrectinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude EU/1//06/343/01 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 0.05 mg/ml oral solution EU/1/06/343/05 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 0.5 mg film-coated tablets EU/1/06/343/001,3,6 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Baraclude 1 mg film-coated tablets EU/1/06/343/02,04,07 |
Entecavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 10 mg Capsule hard EU/1/23/1716/005-006/011 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 15 mg Capsule hard EU/1/23/1716/007-008/012 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 2.5 mg Capsule hard EU/1/23/1716/001-002/009 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 5 mg Capsule hard EU/1/23/1716/003-004/010 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Eliquis 2.5 mg film-coated tablets EU/1/11/691/001-005, 013 |
Apixaban |
Bristol-Myers Squibb Pharma EEIG |
— |
| Eliquis 5 mg film-coated tablets EU/1/11/691/006-012 |
Apixaban |
Bristol-Myers Squibb Pharma EEIG |
— |
| Empliciti 300 mg powder for concentrate for solution for infusion. EU/1/16/1088/001 |
Elotuzumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Empliciti 400 mg powder for concentrate for solution for infusion. EU/1/16/1088/002 |
Elotuzumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| EVOTAZ 300 mg/150 mg film-coated tablets EU/1/15/1025/001-002 |
Atazanavir, Cobicistat |
Bristol-Myers Squibb Pharma EEIG |
— |
| Imnovid 1 mg hard capsules EU/1/13/850/001 |
Pomalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Imnovid 2 mg hard capsules EU/1/13/850/002 |
Pomalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Imnovid 3 mg hard capsules EU/1/13/850/003 |
Pomalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Imnovid 4 mg hard capsules EU/1/13/850/004 |
Pomalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| KRAZATI 200 mg film-coated tablets EU/1/23/1744/001-002 |
Adagrasib |
Bristol-Myers Squibb Pharma EEIG |
— |
| NULOJIX 250 mg powder for concentrate for solution for infusion EU/1/11/694/001-002 |
Belatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| OPDIVO 10 mg/mL concentrate for solution for infusion EU/1/15/1014/001-004 |
Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| OPDIVO 600 mg solution for injection EU/1/15/1014/005 |
Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Opdualag 240 mg/80 mg sterile concentrate EU/1/22/1679/001 |
RELATLIMAB, Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/004-009 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/011-012 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 250 mg powder for concentrate for solution for infusion EU/1/07/389/1-3 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 50 mg solution for injection in pre-filled syringe EU/1/07/389/013 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 87.5 mg solution for injection in pre-filled syringe EU/1/07/389/014 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reblozyl 25 mg powder for solution for injection EU/1/20/1452/001 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reblozyl 75 mg powder for solution for injection EU/1/20/1452/002 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 10 mg hard capsules EU/1/07/391/002 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 15 mg hard capsules EU/1/07/391/003 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 2.5 mg hard capsules EU/1/07/391/005 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 20 mg hard capsules EU/1/07/391/009 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 25 mg hard capsules EU/1/07/391/004 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 5 mg hard capsules EU/1/07/391/001 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 7.5 mg hard capsules EU/1/07/391/006 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz EU/1/03/267/01-7 |
Atazanavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 300 mg hard capsules EU/1/03/267/8-9 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 50 mg oral powder EU/1/03/267/012 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| SOTYKTU 6 mg Film-coated tablet EU/1/23/1718/001-008 |
Deucravacitinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 10 mg/mL powder for oral suspension EU/1/06/363/016 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 100 mg film-coated tablets EU/1/06/363/010-11 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 140 mg film-coated tablets EU/1/06/363/014-015 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 20 mg film-coated tablets EU/1/06/363/1-4-7 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 50 mg film-coated tablet EU/1/06/363/2-5-8 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 70 mg film-coated tablets EU/1/06/363/3-6-9 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 80 mg film-coated tablets EU/1/06/363/012-013 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |